Yiqi Gubiao pill for COPD with active tuberculosis
Part of Infections, Lungs & breathing clinical trials.
This trial tests a traditional Chinese herbal pill (Yiqi Gubiao) to see if it helps people with both COPD and active tuberculosis. It may offer a new way to treat both conditions together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have active tuberculosis (confirmed by a doctor).
- You have not taken steroids, anti-tuberculosis drugs, or other immune-suppressing medicines in the last month.
- You agree to the treatment plan and sign a consent form.
- You do not have other serious lung diseases (like collapsed lung, fluid around the lung, or lung cancer).
- You do not have severe heart, brain, liver, or kidney disease, a mental illness, or a weak immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a Chinese herbal formula (BaiDiZiYin ShenQiYiFei) to standard tuberculosis drugs helps improve symptoms like shortness of breath, fatigue, and coughing. It may be helpful for people diagnosed with pulmonary TB who also have signs of Qi and Yin deficiency (a traditional Chinese medicine pattern).
This trial tests a traditional Chinese medicine granule called Guben Kechuan to help people with COPD recover faster after a hospital stay for a flare-up. It may improve your immune system and reduce inflammation.
This trial tests a Chinese herbal prescription (Bufei Yishen) to see if it can reduce frequent acute flare-ups in people with stable COPD. It may help if you've had multiple exacerbations despite using a triple inhaler for at least 3 months.
This trial tests whether two Chinese herbal medicines, Bailing capsules and Guben Kechuan granules, can help people with stable bronchiectasis. It aims to reduce flare-ups and improve lung function.
This trial tests a traditional Chinese herbal compound formula for people with COPD. It aims to see if the herbal treatment can help improve lung health when used on top of standard inhaler therapy.
This trial tests whether adding a Chinese herbal formula (Yiqi Huoxue Jiedu) and inhaled bacteriophages (viruses that kill bacteria) to standard care can help treat severe pneumonia caused by drug-resistant bacteria like Klebsiella, Acinetobacter, or Pseudomonas. It is for adults aged 18 to 85 who are not pregnant or immunocompromised and can undergo a bronchoscopy to collect samples.
Hear when a new Tuberculosis-related Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.